Search Results - "Alberati, Daniela"

Refine Results
  1. 1

    Glycine Transporter Type I (GlyT1) Inhibitor, Bitopertin: A Journey from Lab to Patient by Pinard, Emmanuel, Borroni, Edilio, Koerner, Annette, Umbricht, Daniel, Alberati, Daniela

    Published in Chimia (22-08-2018)
    “…Glycine transporter-1 (GlyT1) inhibition has been extensively studied both in pharmaceutical companies and academic institutions primarily as a potential new…”
    Get full text
    Journal Article
  2. 2

    Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia by Alberati, Daniela, Moreau, Jean-Luc, Lengyel, Judith, Hauser, Nicole, Mory, Roland, Borroni, Edilio, Pinard, Emmanuel, Knoflach, Frederic, Schlotterbeck, Götz, Hainzl, Dominik, Wettstein, Joseph G.

    Published in Neuropharmacology (01-02-2012)
    “…Dysfunctional N-methyl- d-aspartate (NMDA) receptor neurotransmission has been implicated in the pathophysiology of schizophrenia. It is thought that this…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal–lesioned rats: reversal by glycine and a glycine transporter inhibitor by Le Pen, Gwenaëlle, Kew, James, Alberati, Daniela, Borroni, Edilio, Heitz, Marie-Paule, Moreau, Jean-Luc

    Published in Biological psychiatry (1969) (01-12-2003)
    “…Neonatal ventral hippocampal (NVH) lesions in rats induce behavioral abnormalities at adulthood thought to simulate some aspects of the positive, negative, and…”
    Get full text
    Journal Article
  5. 5

    Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression by Gabernet, Laetitia, Pauly-Evers, Meike, Schwerdel, Cornelia, Lentz, Michèle, Bluethmann, Horst, Vogt, Kaspar, Alberati, Daniela, Mohler, Hanns, Boison, Detlev

    Published in Neuroscience letters (03-01-2005)
    “…The occupation of the glycine binding-site is a prerequisite for NMDA receptor activation by glutamate. To analyze the regulation of NMDA receptor function by…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions by Yohn, Samantha E., Alberati, Daniela, Correa, Merce, Salamone, John D.

    Published in Psychopharmacology (01-05-2017)
    “…Rationale Motivated behavior can be characterized by a substantial exertion of effort, and organisms often make effort-related decisions based upon analyses of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Effects of GlyT1 inhibition on erythropoiesis and iron homeostasis in rats by Winter, Michael, Funk, Jürgen, Körner, Annette, Alberati, Daniela, Christen, Francois, Schmitt, Georg, Altmann, Bernd, Pospischil, Andreas, Singer, Thomas

    Published in Experimental hematology (01-10-2016)
    “…Glycine is a key rate-limiting component of heme biosynthesis in erythropoietic cells, where the high intracellular glycine demand is primarily supplied by the…”
    Get full text
    Journal Article
  12. 12

    Preclinical Reproductive and Developmental Toxicity Profile of a Glycine Transporter Type 1 (Glyt1) Inhibitor by Barrow, Paul, Parrott, Neil, Alberati, Daniela, Paehler, Axel, Koerner, Annette

    “…Bitopertin is a glycine type 1 (GlyT1) inhibitor intended for the treatment of psychiatric disorders. The principle adverse effect in the regulatory…”
    Get full text
    Journal Article
  13. 13

    Physiologically Based Pharmacokinetic Modelling to Predict Single- and Multiple-Dose Human Pharmacokinetics of Bitopertin by Parrott, Neil, Hainzl, Dominik, Alberati, Daniela, Hofmann, Carsten, Robson, Richard, Boutouyrie, Bruno, Martin-Facklam, Meret

    Published in Clinical pharmacokinetics (01-08-2013)
    “…Background Bitopertin (RG1678) is a glycine reuptake inhibitor currently in phase 3 trials for treatment of schizophrenia. This paper describes the use of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Alterations in High-Frequency Neuronal Oscillations in a Cynomolgus Macaque Test of Sustained Attention Following NMDA Receptor Antagonism by Goonawardena, Anushka V, Heiss, Jaime, Glavis-Bloom, Courtney, Trube, Gerhard, Borroni, Edilio, Alberati, Daniela, Wallace, Tanya L

    Published in Neuropsychopharmacology (New York, N.Y.) (01-04-2016)
    “…A growing body of evidence indicates that neuronal oscillations in the gamma frequency range (30-80 Hz) are disturbed in schizophrenic patients during…”
    Get full text
    Journal Article
  16. 16

    Pre-clinical characterization of [11C]R05013853 as a novel radiotracer for imaging of the glycine transporter type 1 by positron emission tomography by Borroni, Edilio, Zhou, Yun, Ostrowitzki, Susanne, Alberati, Daniela, Kumar, Anil, Hainzl, Dominik, Hartung, Thomas, Hilton, John, Dannals, Robert F., Wong, Dean F.

    Published in NeuroImage (Orlando, Fla.) (15-07-2013)
    “…A specific positron emission tomography (PET) radiotracer for the glycine transporter type 1 (GlyT1) would constitute an imaging biomarker to investigate the…”
    Get full text
    Journal Article
  17. 17

    Pharmacological evaluation of a novel assay for detecting glycine transporter 1 inhibitors and their antipsychotic potential by Alberati, Daniela, Moreau, Jean-Luc, Mory, Roland, Pinard, Emmanuel, Wettstein, Joseph G.

    Published in Pharmacology, biochemistry and behavior (01-12-2010)
    “…Multiple lines of evidence support the notion that hypofunction of glutamatergic neurotransmission is involved in the pathophysiology of schizophrenia…”
    Get full text
    Journal Article
  18. 18

    Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells by Alberati-Giani, D, Ricciardi-Castagnoli, P, Köhler, C, Cesura, A M

    Published in Journal of neurochemistry (01-03-1996)
    “…Several pieces of evidence suggest a major role for brain macrophages in the overproduction of neuroactive kynurenines, including quinolinic acid, in brain…”
    Get more information
    Journal Article
  19. 19
  20. 20